Ibandronate in the Treatment of Pediatric Osteoporosis

被引：1
|
作者：
Kutilek, Stepan [1 ,2 ]
Plasilova, Ivana [1 ]
Langer, Jan [3 ]
机构：
[1] Pardubice Hosp, Dept Pediat, Pardubice, Czech Republic
[2] Klatovy Hosp, Dept Pediat, Klatovy, Czech Republic
[3] Charles Univ Prague, Dept Pediat, Med Facil 1, Prague, Czech Republic
来源：
INDIAN PEDIATRICS | 2016年 / 53卷 / 10期
关键词：
Bone mineral density; Fractures; Ibandronate; MONTHLY ORAL IBANDRONATE; CHILDREN;
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
We administered oral ibandronate (once a month) to 7 children (6 boys) with low bone mineral density and prevalent low energy fractures. We observed a significant increase (17%) in bone density after one year and additional 3% increase after second year. No further fractures occurred.
引用
收藏
页码：927 / 927
页数：1
相关论文
共 50 条
  • [41] Ibandronate and prevention of postmenopausal osteoporosis - Reply
    Stakkestad, JA
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (05) : 609 - 610
  • [42] Parenteral Ibandronate in the Therapy of postmenopausal Osteoporosis
    Broell, H.
    Dobnig, H.
    Resch, H.
    Erlacher, L.
    Fahrleitner-Pammer, A.
    Finkenstedt, G.
    Holzer, G.
    Pietschmann, P.
    Pirich, C.
    Wicker, A.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 : 2 - 8
  • [43] Ibandronate: A Review in Japanese Patients with Osteoporosis
    Keating, Gillian M.
    DRUGS & AGING, 2016, 33 (04) : 295 - 303
  • [44] Ibandronate: A Review in Japanese Patients with Osteoporosis
    Gillian M. Keating
    Drugs & Aging, 2016, 33 : 295 - 303
  • [45] BEATRIS - BETTER ADHERENCE TO TREATMENT WITH IBANDRONATE IN OSTEOPOROSIS: BONE MARKER FEEDBACK STUDY
    Goemaere, S.
    Pornel, B.
    Mathy, L.
    van Steenberghe, M.
    Tomas, M.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 23 - 23
  • [46] Ibandronate treatment for osteoporosis: Rationale, preclinical, and clinical development of extended dosing regimens
    Epstein S.
    Current Osteoporosis Reports, 2006, 4 (1) : 14 - 20
  • [47] Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis: a review
    Miller, P. D.
    Ward, P.
    Pfister, T.
    Leigh, C.
    Body, J. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (06) : 1125 - 1133
  • [48] Denosumab for the treatment of primary pediatric osteoporosis
    Anastasilakis, A. D.
    Makras, P.
    Doulgeraki, A.
    Polyzos, S. A.
    Guarnieri, V.
    Papapoulos, S. E.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (11) : 2377 - 2381
  • [49] Causes, diagnosis, and treatment of pediatric osteoporosis
    Lim, Jung Sub
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2018, 61 (10): : 616 - 622
  • [50] Pediatric Osteoporosis: Diagnosis and Treatment Considerations
    Edoardo Marrani
    Teresa Giani
    Gabriele Simonini
    Rolando Cimaz
    Drugs, 2017, 77 : 679 - 695
12345